RU2559544C2 - Method for production of dry tableted milk-based products of general and functional purpose - Google Patents

Abstract

FIELD: food industry.

SUBSTANCE: invention relates to dairy industry. The composition includes sources of nonfat milk solids - skimmed milk and/or dry demineralised whey and/or dry lactose, as well as a sweetening component represented by fructose in an amount of 10-30%, fillers represented by fruit, berry, vegetable or cereal ingredients accounting (individually or in total) for 5-20% and sublimation dried probiotic cultures of propionic acid bacteria Propionobacterium freudenreichii subsp. Shermanii and/or bifidobacteria Bifidobacterium adolesescentis and/or acidophilic lactic acid rod bacteria Lactobacillus acidophilus and/or mesophilic lactic acid rod bacteria Lactobacillus cassei, Lactobacillus rhamnosus accounting (individually or in total) for 0-20%, biologically active substances - carotinoid lycopene, bioflavonoid dihydroquercetin, polysaccharide arabinogalactan, vitamin complexes accounting (individually or in total) for 0-5% with account for individual components consumption norms, oligosaccharides - lactulose and isomaltulose accounting for 0-20%, auxiliary substances of structuring and destructuring purpose - starches, cellulose, water, gelatine, sugar, talc, calcium and magnesium stearates, aerosil, paraffin, pectin accounting for 0-5%. One prepares the recipe composition by way of mixing under aseptic conditions dry skimmed cow residue in an amount so that the fraction of other components in the product is 20-50%. One performs material supply into the matrix and its cold compression moulding with a force plunger under a pressure of 5-25 MPa; tablets are forced from the matrix, dedusted and packaged into consumer containers such as blisters, strips, jars, bottles, boxes and other forms with the form tableting density equal to 1250-1750 kg/m³. The product may have a concavo-convex, spherical, cubic or fancy form and a weight of 0.5 to 10 g.

EFFECT: invention ensures extension of the range of technical means and preservation of the initial flavouring components.

5 ex

Description

The invention relates to the dairy industry, in particular to a technology for the production of milk-based products.

An analysis of the existing problems of the popularization of dairy products and the increase in their consumption showed that research and development of technologies for functional food products should be inextricably linked with industrial production and the possibility of their commercialization. Popularization of dairy products is possible not only within the framework of expanding the range of functional dairy products, but also creating fundamentally new forms of products. Currently, studies aimed at developing dry tabletted phytolactate products are particularly relevant, since these products have a high potential for feasibility due to the long shelf life and availability for all age and target categories of the population, high nutritional and biological values due to the balanced composition and enrichment with functional ingredients.

The advantages of tableted food products are a significant reduction in energy costs for their storage, transportation and sale by reducing warehouse production space, in convenience and ease of use for direct consumption in food, as well as the possibility of using special contingent in the diet. An important advantage of tabletting is also the possibility of combining substances incompatible in their physicochemical properties.

To increase the biological value of the product, it is advisable to enrich it with biologically active substances such as carotenoid lycopene, bioflavonoid dihydroquercetin, which have antioxidants and geroprotective properties, arabinogalactan polysaccharide, which has prebiotic, immunostimulating, hepato and mebranoprotective properties, and other vitamin. with sweetening properties it is advisable to use carbohydrates with a low glycemic index th and metabolic rate. So, in particular, fructose is not absorbed by insulin-dependent tissues, is included in the metabolism without conflict, and has recommendations for use by persons suffering from various diseases, including diabetes, and in the manufacture of products for the elderly. The process of isomaltulose metabolism consists in the fact that the hydrolysis of isomaltulose, like fructose, proceeds much slower than the hydrolysis of sucrose, which indicates the possibility of reducing the glycemic and insulin response in healthy people and patients with type 2 diabetes, which are insulin-independent when consuming this carbohydrate. The introduction of lactulose additionally gives the product prebiotic properties.

Analogues of the proposed method for the production of dry tabletted milk-based products were not found.

The technical result of the present invention is the creation of a dry tablet product for oral administration (oral and / or oral administration) of a plane-cylindrical, biconvex, spherical, cubic or other (including fantasy) forms weighing from 0.5 to 10 g and containing dry skim milk residue (СОМО) in the product from 20 to 50%, the sweetening component of fructose from 10 to 30%, fillers from 5 to 20%, starter cultures from 0 to 20%, biologically active substances (carotenoid lycopene, bioflavonoid dihydr okvercetin, arabinogalactan polysaccharide, vitamin complexes in combination and / or separately, etc.) from 0 to 5%, oligosaccharides from 0 to 20%, auxiliary substances from 0 to 5%, produced by dry mixing of these components, feeding the material into the matrix, compressing (molding) it in a cold state with a punch, pushing a tablet out of a matrix, dropping a tablet into a tray and packing it in a consumer container like blisters, convolutes, cans, bottles, boxes and other forms permitted for use by the legislation of the Russian Federation.

The technical result is achieved by the fact that to obtain a dry tablet product for oral administration (oral and / or oral administration) of a plane-cylindrical, biconvex, spherical, cubic or other (including fantasy) forms weighing from 0.5 to 10 g, the formulation is prepared by dry mixing under aseptic conditions of skimmed milk powder (SOMO) based on obtaining in the finished product from 20 to 50% (skimmed milk powder and / or dry demine are used as SOMO sources alizovannuyu serum and / or dry lactose), sweetening component - fructose based obtain the finished product of from 10 to 30%; fillers (dry fruit, berry, vegetable, cereal ingredients individually or compositionally) based on the receipt in the finished product from 5 to 20%; freeze-dried probiotic cultures of propionic acid bacteria (Propionobacterium freudenreichii subsp. Shermanii) and / or bifidobacteria (Bifidobacterium adolesescentis), and / or acidophilic lactic acid bacilli (Lactobacillus acidophilus), and / or mesophilus lactobacillus lactobacillus a product from 0 to 20% individually or compositionally; biologically active substances (carotenoid lycopene, bioflavonoid dihydroquercetin, arabinogalactan polysaccharide, vitamin complexes in combination and / or separately, etc.) based on the calculation of 0 to 5% in the finished product and taking into account the norms of consumption of individual components; oligosaccharides (lactulose, isomaltulose, etc.) based on the receipt in the finished product from 0 to 20% and taking into account the norms of consumption of individual components; excipients (structuring and destructuring substances - starches, cellulose, water, gelatin, sugar, talc, calcium and magnesium stearates, aerosil, paraffin, pectin) from 0 to 5%, feed the material into the matrix, compress (molding) it in cold condition of the punch (at a pressure of 5 to 25 MPa), pushing the tablets out of the matrix, dust removal and packaging in consumer containers like blisters, convolutes, cans, bottles, boxes and other forms permitted for use by the legislation of the Russian Federation. The density of the tablet forms can range from 1250 to 1750 kg / m ³ .

Example 1

To obtain 100 kg of a dry, dairy-based tablet product with a tablet weight of 0.5 g (200,000 tablets), the technical result is achieved by weighing and mixing under aseptic conditions: 15 kg of skimmed milk powder, 5 kg of demineralized whey powder, 30 kg fructose, 5 kg of freeze-dried dry cherry, 20 kg of sublimated probiotic cultures of propionic acid bacteria - Propionobacterium freudenreichii subsp. shermanii, bifidobacteria - Bifidobacterium adolesescentis, acidophilic lactic acid bacilli - Lactobacillus acidophilus, mesophilic lactic acid bacilli - Lactobacillus cassei compositionally 5 kg each; 5 kg of biologically active substances - 0.5 kg lycopene carotenoid, 0.5 kg bioflavonoid dihydroquercetin, 4 kg arabinogalactan polysaccharide, 1 kg vitamin complexes; 15 kg of lactulose oligosaccharide in dry form; 5 kg of auxiliary substances - starch 1 kg, water 1 kg, talc 0.5 kg, aerosil 1 kg, pectin 1.5 kg, feeding the material into the matrix, compressing and molding it in the cold state with a punch at a pressure of 5 MPa, pushing the tablet out matrices, dust removal and packaging in consumer containers like blisters. The density of the tablet forms can range from 1250 to 1300 kg / m ³ .

The product is characterized by a light lilac color, with the taste and smell of milk and cherry, sweet. Designed for general and functional use, oral and oral administration.

Example 2

To obtain 100 kg of a dry, dairy-based tablet product with a tablet weight of 10 g (10,000 tablets), the technical result is achieved by weighing and mixing under aseptic conditions: 40 kg of skimmed milk powder, 10 kg of dry lactose, 10 kg of fructose, 5 kg dry freeze-dried strawberries; 10 kg of sublimated probiotic cultures of propionic acid bacteria - Propionobacterium freudenreichii subsp. Shermanii; 2 kg of biologically active substances - bioflavonoid dihydroquercetin 1 kg, arabinogalactan polysaccharide 1 kg; 20 isomaltulose oligosaccharide in dry form; 3 kg of auxiliary substances - starch 1 kg, paraffin 1 kg, aerosil 1 kg, feeding the material into the matrix, compressing it into a cold state with a punch at a pressure of 20 MPa, pushing the tablet out of the matrix, removing dust and packing it into containers like jars. The density of the tablet forms can range from 1350 to 1400 kg / m ³ .

The product is characterized by a light pink color with the taste and smell of milk and strawberries, moderately sweet. Designed for general and functional use, oral and oral administration.

Example 3

To obtain 100 kg of a dry, dairy-based tablet product with a tablet weight of 5 g (20,000 tablets), the technical result is achieved by weighing and mixing under aseptic conditions: 20 kg of skimmed milk powder, 5 kg of demineralized whey powder, 25 kg of dry lactose , 20 kg of fructose, 20 kg of dry crushed oatmeal, 5 kg of sublimated probiotic cultures of bifidobacteria - Bifidobacterium adolesescentis; 5 kg of auxiliary substances - starch 1 kg, water 1 kg, talc 0.5 kg, aerosil 1 kg, pectin 1.5 kg, feeding the material into the matrix, compressing and molding it in the cold state with a punch at a pressure of 25 MPa, pushing the tablet out matrices, dust removal and packaging in consumer containers like convoys. The density of the tablet forms can range from 1500 to 1550 kg / m ³ .

The product is characterized by a light cream color, with the taste and smell of milk and cereals, sweet. Designed for general and functional use, oral and oral administration.

Example 4

To obtain 100 kg of a dry, dairy-based tablet product with a tablet weight of 1 g (100,000 tablets), the technical result is achieved by the fact that under aseptic conditions, 30 kg of skimmed milk powder, 5 kg of demineralized whey powder, 25 kg of fructose, 15 are weighed and mixed. kg dry freeze dried bell pepper, 20 kg freeze-dried probiotic cultures of propionic acid bacteria - Propionobacterium freudenreichii subsp. Shermanii and bifidobacteria - Bifidobacterium adolesescentis compositionally 10 kg each; 3 kg of biologically active substances - bioflavonoid dihydroquercetin 2 kg, arabinogalactan polysaccharide 1 kg; 20 kg dry lactulose oligosaccharide; 5 kg of auxiliary substances - starch 1 kg, talc 1.5 kg, aerosil 1 kg, pectin 1.5 kg, feeding the material into the matrix, compressing it into a cold state by a punch at a pressure of 10 MPa, expelling the tablet from the matrix, dedusting and packaging in consumer containers like blisters. The density of the tablet forms can range from 1350 to 1400 kg / m ³ .

The product is characterized by a light shade of the color of bell pepper, with the taste and smell of milk and pepper, sweet. Designed for general and functional use, oral and oral administration.

Example 5

To obtain 100 kg of a dry tablet product on a milk basis with a tablet weight of 2.5 g (40,000 tablets), the technical result is achieved by the fact that, under aseptic conditions, 50 kg of dry lactose, 30 kg of fructose, 5 kg of dry freeze-dried peach are weighed, 15 kg of lactulose oligosaccharide in dry form, mix, feed the material into the matrix, compress-form it in the cold state with a punch at a pressure of 25 MPa, push the tablet out of the matrix, remove dust and pack it in a consumer container like orobok. The density of the tablet forms can range from 1700 to 1750 kg / m ³ .

The product is characterized by a light beige color, with the taste and smell of milk and peach, sweet. Designed for general and functional use, oral and oral administration.

Claims (1)

A method for the production of dry dairy-based tablet products for oral and / or oral use of a cylindrical, biconvex, spherical, cubic or other, including fancy, molds weighing from 0.5 to 10 g, comprising preparing a prescription composition by dry mixing under aseptic conditions skimmed milk powder residue in the calculation of obtaining from 20 to 50% in the finished product, while skimmed milk powder and / or demineralized whey powder are used as SOMO sources, and / or dry lactose; the sweetening component is fructose, based on the receipt in the finished product from 10 to 30%; fillers - dry fruit, berry, vegetable, cereal ingredients individually or compositionally, based on the receipt in the finished product from 5 to 20%; sublimated probiotic cultures of propionic acid bacteria - Propionobacterium freudenreichii subsp. Shermanii and / or bifidobacteria - Bifidobacterium adolesescentis, and / or acidophilic lactobacillus bacilli - Lactobacillus acidophilus, and / or mesophilic lactic acid bacilli - Lactobacillus cassei, Lactobacillus rhamnosus from the calculation of 0 to 100% individually or in the finished product biologically active substances - carotenoid lycopene, bioflavonoid dihydroquercetin, arabinogalactan polysaccharide, vitamin complexes in combination and / or separately from the calculation of obtaining from 0 to 5% in the finished product and taking into account the norms of consumption of individual components; oligosaccharides - lactulose, isomaltulose based on the receipt in the finished product from 0 to 20% and taking into account the consumption rates of individual components; auxiliary substances of structuring and destructuring purposes - starches, cellulose, water, gelatin, sugar, talc, calcium and magnesium stearates, aerosil, paraffin, pectin from 0 to 5%, feeding the material into the matrix, compressing and molding it in the cold state with a punch at pressure from 5 to 25 MPa, pushing the tablet out of the matrix, dedusting and packaging in consumer containers like blisters, convolutes, cans, bottles, boxes and other forms with tablet density of forms from 1250 to 1750 kg / m ³ .